Pauwels Ruben, Cockmartin Lesley, Ivanauskaité Deimante, Urbonienė Ausra, Gavala Sophia, Donta Catherine, Tsiklakis Kostas, Jacobs Reinhilde, Bosmans Hilde, Bogaerts Ria, Horner Keith
OMFS-IMPATH Research Group, Oral Imaging Center, Department of Imaging and Pathology, Faculty of Medicine, Catholic University of Leuven, Leuven, Belgium. Department of Radiology, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand.
Phys Med Biol. 2014 Jul 21;59(14):3877-91. doi: 10.1088/0031-9155/59/14/3877. Epub 2014 Jun 24.
The aim of this study was to measure entrance skin doses on patients undergoing cone-beam computed tomography (CBCT) examinations, to establish conversion factors between skin and organ doses, and to estimate cancer risk from CBCT exposures. 266 patients (age 8-83) were included, involving three imaging centres. CBCT scans were acquired using the SCANORA 3D (Soredex, Tuusula, Finland) and NewTom 9000 (QR, Verona, Italy). Eight thermoluminescent dosimeters were attached to the patient's skin at standardized locations. Using previously published organ dose estimations on various CBCTs with an anthropomorphic phantom, correlation factors to convert skin dose to organ doses were calculated and applied to estimate patient organ doses. The BEIR VII age- and gender-dependent dose-risk model was applied to estimate the lifetime attributable cancer risk. For the SCANORA 3D, average skin doses over the eight locations varied between 484 and 1788 µGy. For the NewTom 9000 the range was between 821 and 1686 µGy for Centre 1 and between 292 and 2325 µGy for Centre 2. Entrance skin dose measurements demonstrated the combined effect of exposure and patient factors on the dose. The lifetime attributable cancer risk, expressed as the probability to develop a radiation-induced cancer, varied between 2.7 per million (age >60) and 9.8 per million (age 8-11) with an average of 6.0 per million. On average, the risk for female patients was 40% higher. The estimated radiation risk was primarily influenced by the age at exposure and the gender, pointing out the continuing need for justification and optimization of CBCT exposures, with a specific focus on children.
本研究的目的是测量接受锥形束计算机断层扫描(CBCT)检查的患者的体表入射剂量,建立体表剂量与器官剂量之间的转换系数,并估算CBCT照射所致的癌症风险。纳入了266名年龄在8至83岁之间的患者,涉及三个影像中心。使用SCANORA 3D(芬兰图苏拉的Soredex公司)和NewTom 9000(意大利维罗纳的QR公司)进行CBCT扫描。八个热释光剂量计附着在患者体表的标准化位置。利用先前发表的关于各种CBCT的人体模型器官剂量估计值,计算将体表剂量转换为器官剂量的相关系数,并应用于估算患者的器官剂量。应用BEIR VII年龄和性别相关的剂量风险模型来估算终生归因癌症风险。对于SCANORA 3D,八个位置的平均体表剂量在484至1788微戈瑞之间。对于NewTom 9000,中心1的范围在821至1686微戈瑞之间,中心2的范围在292至2325微戈瑞之间。体表入射剂量测量显示了照射和患者因素对剂量的综合影响。终生归因癌症风险,以患辐射诱发癌症的概率表示,在百万分之2.7(年龄>60岁)至百万分之9.8(年龄8至11岁)之间,平均为百万分之6.0。平均而言,女性患者的风险高40%。估计的辐射风险主要受照射时的年龄和性别的影响,这表明持续需要对CBCT照射进行正当性论证和优化,尤其要关注儿童。